Today we are taking a look at our COVID-19 research data and exploring where in the world most research into the SARS-CoV-2 virus is being carried out, and which institutions are most active.
Exploring our COVID-19 dataset allows reagent suppliers to create an informed product pipeline and to make validation and sales and marketing decisions that reflect the needs of their customers. Our dataset covers both COVID-19 specific reagents, along with those used in COVID-19 related research papers.
Rhys Bowen Morris, product manager at CiteAb, said: “Our COVID-19 dataset provides a comprehensive and unbiased view of the coronavirus reagent market. It provides a view of the reagents that are specifically raised to study Sars-CoV-2 (and other coronaviruses) and also reagents that are not specifically for Sars-CoV-2 research, but have been used in Coronavirus research publications.”
When we analyse this data we can see which institutions in which countries are carrying out the most COVID-19 research, and where certain types of product are being used.
We can share today that the United States makes us the largest portion of the COVID-19 research market, with a 40 per cent share in citations. China closely follows with 22 per cent, and Germany has 7 per cent. This essentially shows us that almost 70 per cent of all COVID-19 research is being carried out by just three countries – an insight that should help to shape the marketing of COVID-19 reagents.
Other nations with a presence in the COVID-19 research space are Spain, the Republic of Korea, the United Kingdom and Italy.
By drilling down a little further into the data, we can also see that despite certain nations carrying out large amounts of COVID-19 research, there are differences in the products that they have been using.
Rhys explains: “In the US, the most cited reagent in COVID-19 related papers is SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody (GTX632604) from genetex, which detects the SARS-CoV-2 spike proteins (S2 subunit). In China the most cited is ACE2 antibody (21115-1-AP) from proteintech, a host protein which is a functional receptor of the SARS-CoV-2 virus.”
However, there are also similarities between product use in countries. Rhys adds: “The most cited cell line in both the US and in China was VERO C1008 (CRL-1586) from ATCC, which proves a popular experimental model for use in COVID-19 research”.
When we start to drill down to what is happening at an institutional level, we can see that the most active institution is not in the US, but in China, with Peking Union Medical College holding 3.39% of citations. However after this, US institutions do dominate the remaining top ten, including Cornell University and the Universities of Washington and Pennsylvania.
Beyond the US and China, other institutions active in COVID-19 research include the Karolinska Institute in Solna, Sweden, and Qatar University. Rhys adds” “Neither of these institutions were present in the top 10 institutions of Coronavirus related research prior to 2020, showing that they have stepped up to the challenge during the pandemic. This demonstrates how fast-changing the COVID-19 research field is, and how important it is for reagent suppliers to keep an eye on trends so that they can maximise the value of their marketing and ensure their product pipeline reflects research needs.”
The full CiteAb COVID-19 dataset covers over 1.25 million data points, with over 7000 products from 145 suppliers in academic publications from over 80 countries. The data covers reagents for SARS-COV-2, SARS and MERS, other coronaviruses from all species, host proteins, products associated with the viral life cycle, and many others. It is collected from a wide variety of reagent types including antibodies, kits and proteins, as well as biochemicals and cell lines. Over 24,000 unique citations have been collected so far, and we continually work to update this dataset as research in the field continues apace.
Today we’re giving away two small elements of our full COVID-19 dataset for free – the top ten countries and top ten institutions cited in COVID-19 research. To receive your free copy direct to your inbox, sign up using the form below. And as always, if you’ve any questions about this dataset please don’t hesitate to contact Rhys and he’ll be more than happy to help.
- Rebecca and the CiteAb team
Sign up for data
Something seems to have gone wrong while loading the form.
Drop us a message and we can send you the data directly.